OUTLOOK THERAPEUTICS, INC.: 10-Q filed 2019-02-14

Name: OUTLOOK THERAPEUTICS, INC.: 10-Q filed 2019-02-14
Creator: OUTLOOK THERAPEUTICS, INC.

What OUTLOOK THERAPEUTICS, INC. reported in its quarterly report filed 2019-02-14 (fiscal Q1 2019): 35 published measures, 70 facts as tagged in accession 0001144204-19-008128.

This filing

Form: 10-Q (quarterly report)
Filed: 2019-02-14
Fiscal period: fiscal Q1 2019
Accession: 0001144204-19-008128 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OUTLOOK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-12-31	18,709,699	USD
At 2018-09-30	22,283,495	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-12-31	40,179,039	USD
At 2018-09-30	43,094,001	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-12-31	-26,354,264	USD
At 2018-09-30	-25,544,922	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-12-31	227,716	USD
At 2018-09-30	1,717,391	USD
At 2017-12-31	13,837,779	USD
At 2017-09-30	3,185,519	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-9,741,844	USD	92
2017-10-01 to 2017-12-31	-1,920,501	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-9,803,686	USD	92
2017-10-01 to 2017-12-31	-8,671,077	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	236,433	USD	92
2017-10-01 to 2017-12-31	1,075,143	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	1,067,598	USD	92
2017-10-01 to 2017-12-31	771,890	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	8,528,133	USD	92
2017-10-01 to 2017-12-31	20,398,480	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-236,433	USD	92
2017-10-01 to 2017-12-31	-1,075,143	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-12-31	-229,698,465	USD
At 2018-09-30	-216,307,363	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-3,150,716	USD	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-12-31	15,941,866	USD
At 2018-09-30	18,489,976	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	872,289	USD	92
2017-10-01 to 2017-12-31	1,889,820	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-10,257,315	USD	92
2017-10-01 to 2017-12-31	-3,179,764	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-12-31	2,305,507	USD
At 2018-09-30	3,302,480	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	1,120,849	USD	92
2017-10-01 to 2017-12-31	717,883	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-12-31	27,535,821	USD
At 2018-09-30	32,042,033	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-12-31	4,696,258	USD
At 2018-09-30	3,609,607	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	11,324,913	USD	92
2017-10-01 to 2017-12-31	3,951,654	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	8,420,925	USD	92
2017-10-01 to 2017-12-31	402,402	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-12-31	85,091,786	shares
At 2018-09-30	72,220,351	shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2018-12-31	28,425,982	USD
At 2018-09-30	30,189,268	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2018-12-31	12,484,116	USD
At 2018-09-30	11,699,292	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-12-31	462,326	USD
At 2018-09-30	491,039	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-12-31	3,397,692	USD
At 2018-09-30	3,514,738	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2018-12-31	4,520,883	USD
At 2018-09-30	6,458,471	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-12-31	2,077,791	USD
At 2018-09-30	1,585,089	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-9,741,844	USD	92
2017-10-01 to 2017-12-31	-5,071,217	USD	92

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-9,892,352	USD	92
2017-10-01 to 2017-12-31	-17,726,321	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	2,903,988	USD	92
2017-10-01 to 2017-12-31	3,549,252	USD	92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	823,077	USD	92
2017-10-01 to 2017-12-31	676,624	USD	92

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	1,657,157	USD	92
2017-10-01 to 2017-12-31	25,505	USD	92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	11,885,833	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2018-10-01 to 2018-12-31	-260,452	USD	92
2017-10-01 to 2017-12-31	-6,949,861	USD	92

Inspect the source

Entity: OUTLOOK THERAPEUTICS, INC. / CIK 0001649989
Captured: 2026-09-21T17:23:24.422Z
SEC response SHA-256: ce697e8c1ac203fe6827508f0d6a14f8a445ce42f9c031026a98c3f5635933f0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001649989.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))